Although it’s commonly recommended to test for albuminuria in people with diabetes or high blood pressure, testing is often ...

Data analyses from two real-world trials of Rebyota (fecal microbiota, live-jslm)efficacy and safety will be presented at IDWeek 2025, according to the details of a recent Ferring Pharmaceuticals news ...

The oral microbiome is home to more than 700 species of bacteria, and the average person hosts approximately 250 species at a time, according to the study. Each person’s oral microbiome is unique and ...

Patients with Type 1 diabetes are often excluded from diabetes and weight loss trials. Forty years ago, the vast majority of patients with Type 1 diabetes didn’t need help with the problem of being ...

These gaps stem from systemic barriers, including limited access to early detection, follow-up delays and inequities in ...

Conflicting studies on GLP-1 drugs’ vision impacts prompt calls for baseline eye exams and monitoring.

Researchers of the National Eye Institute found that the supplement—now known as the AREDS formula, containing vitamins C and ...

Based on data including more than 788 million patient visits from more than 15,000 ophthalmologists, thousands of eyes were ...

Bandyopadhyay and colleagues found that new T1D registrations were most likely to come from people under the age of 40, ...

Tzield, a monoclonal antibody approved for stage 2 Type 1 diabetes, now seeks approval for stage 3 disease based on trial ...

The new treatments Gilhooley referred to are calcitonin gene-related peptide (CGRP) inhibitors, a class that includes ...

Medicare seems to offer more consistent care across states than other insurance programs; however, where beneficiaries live ...